Invicta Diagnostic Management Change
Invicta Diagnostic Limited reported changes to its leadership and audit team, including a director's re-appointment, a designation change, and a new secretarial auditor.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements
Invicta Diagnostic Limited reported changes to its leadership and audit team, including a director's re-appointment, a designation change, and a new secretarial auditor.
Invicta Diagnostic Limited conducted its 3rd Annual General Meeting on September 19, 2026. The proceedings detailed company operations and future financial targets.
Board approved business outlook and forward-looking guidance for the 3rd AGM on 19 September 2026. Company targets consolidated revenue of ₹45–50 crore with ~25% EBITDA margin.
Invicta's subsidiaries commenced operations at two diagnostic centres in Shegaon and Pune. Investment is Rs. 70 lakhs for CT scan and pathology services.
Invicta Diagnostic (PC Diagnostics) reported FY26 revenue of ₹33.04cr with 31.63% EBITDA margins. Strategy focuses on Maharashtra-based expansion of advanced radiology hubs and strategic acquisitions like Vinchurkar Diagnostics.
Invicta Diagnostic (PC Diagnostics) reported FY26 Total Income of ₹33.04 Cr with 31.63% EBITDA margin. Strategy focuses on radiology-led growth in the Mumbai Metropolitan Region (MMR).
Invicta Diagnostic Ltd reported revenue from operations of ₹15.4 Cr and net profit of ₹0.8 Cr for H2 FY26.